Serum Paraoxonase Activity and Genotype Distribution in Japanese Patients with Diabetes Mellitus

Internal Medicine

Volumn 37, Issue 7, 1998, Pages 581-584

  Sakai, Takenori ^a   Matsuura, Bunzou ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; High density lipoprotein (HDL) cholesterol; Intimal medial thickness (IMT); Non insulin dependent diabetes mellitus (NIDDM); Polymorphism of paraoxonase gene

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; DNA; ESTERASE; HIGH DENSITY LIPOPROTEIN;

ARTICLE; BLOOD; ENZYMOLOGY; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; JAPAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DNA; ESTERASES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0032118543     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.581     Document Type: Article

References (20)

1. Mackness MI, Walker CH. Partial purification and properties of sheep serum 'A'-esterases. Biochem Pharmacol 32: 2291, 1983.
2. Furlong CE, Richter RJ, Seidel SL, Motulsky AG. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am J Hum Genet 43: 230, 1988.
3. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3: 73, 1993.
4. Mackness MI, Harty D, Bhatnagar D, et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 86: 193, 1991.
5. Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 15: 1812, 1995.
6. Ruiz J, Blanche H, James RW, et al. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 346: 869, 1995.
7. Serrato M, Marian AJ. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest 96: 3005, 1995.
8. Eiberg H, Mohr J. Genetics of paraoxonase. Ann Hum Genet 45: 323, 1981.
9. Geldmacher-von Mallinckrodt M, Diepgen TL, Duhme C, Hommel G. A study of the polymorphism and ethnic distribution differences of human serum paraoxonase. Am J Phys Anthropol 62: 235, 1983.
10. Mueller RF, Hornung S, Furlong CE, Anderson J, Giblett ER, Motulsky AG. Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies. Am J Hum Genet 35: 393, 1983.
11. Roy AC, Saha N, Tay JS, Ratnam SS. Serum paraoxonase polymorphism in three populations of southeast Asia. Hum Hered 41: 265, 1991.
12. Wei M, Gonzalez C, Haffner SM, O'Leary DH, Stern MP. Ultrasonographically assessed maximum carotid artery wall thickness in Mexico City residents and Mexican Americans living in San Antonio. Texas. Association with diabetes and cardiovascular risk factors. Arterioscler Thromb Vase Biol 16: 1388, 1996.
13. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles, and description of a computerized analysing system. Clin Physiol 11:565, 1991.
14. Furlong CE, Costa LG, Hassett C, et al. Human and rabbit paraoxonase: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxication. Chem Biol Interact 87: 35, 1993.
15. Reiser KM, Amigable MA, Last JA. Nonenzymatic glycation of type 1 collagen. The effects of aging on preferential glycation sites. J Biol Chem 267:24207, 1992.
16. Beswick HT, Harding JJ. Conformational changes induced in lens alpha-and gamma-crystallins by modification with glucose 6-phosphate. Implications for cataract. Biochem J 246: 761, 1987.
17. Aral K, Maguchi S, Fujii S, Ishibashi H, Oikawa K, Taniguchi N. Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites. J Biol Chem 262: 16969, 1987.
18. Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. Clin Chem 32: B37, 1986.
19. Antikainen M, Murtomaki S, Syvanne M, et al. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest 98:883, 1996.
20. Mackness MI, Durrington PN. High density lipoprotein, its enzymes and their potential to influence lipid peroxidation. Atherosclerosis 115: 243, 1995.